P

Inventor

LONG JIANG

US58 patents
⚠️ This page may combine multiple inventors who share the name “LONG JIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENANTA PHARM INC

41 patents
US10683279B2Jun 16, 2020

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC13 citations94
US11560368B2Jan 24, 2023

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC6 citations86
US11420976B2Aug 23, 2022

Heterocyclic compounds as anti-viral agents

ENANTA PHARM INC7 citations86
US10988458B2Apr 27, 2021

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC7 citations84
US10584145B2Mar 10, 2020

Process for preparation of sulfonylurea bile acid derivatives

ENANTA PHARM INC8 citations84
US10457703B2Oct 29, 2019

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC8 citations84
US10450301B2Oct 22, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC11 citations84
US10253018B2Apr 9, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC10 citations84
US10246439B2Apr 2, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC12 citations84
US10208081B2Feb 19, 2019

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC9 citations84
US9220748B2Dec 29, 2015

Macrocyclic proline derived HCV serine protease inhibitors

ENANTA PHARM INC6 citations84
US8367618B2Feb 5, 2013

Cyclosporin analogues for preventing or treating hepatitis C infection

ENANTA PHARM INC6 citations84
US8367053B2Feb 5, 2013

Cyclosporin analogues

ENANTA PHARM INC9 citations84
US12018017B2Jun 25, 2024

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC1 citations73
US11958879B2Apr 16, 2024

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations73
US11834436B2Dec 5, 2023

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC2 citations73
US11718641B2Aug 8, 2023

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations73
US11040998B2Jun 22, 2021

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC2 citations73
US10968249B2Apr 6, 2021

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10696713B2Jun 30, 2020

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10472386B2Nov 12, 2019

Bile acid derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC6 citations73
US10149835B2Dec 11, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC2 citations73
US10080741B2Sep 25, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10080742B2Sep 25, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10080743B2Sep 25, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC4 citations73
US12552777B2Feb 17, 2026

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations63
US12459923B2Nov 4, 2025

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations63
US11008304B2May 18, 2021

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC1 citations63
US10144729B2Dec 4, 2018

Isoxazole analogs as FXR agonists and methods of use thereof

ENANTA PHARM INC2 citations63
US9221878B2Dec 29, 2015

Cyclosporin analogues for preventing or treating hepatitis C infection

ENANTA PHARM INC3 citations63
US9156886B2Oct 13, 2015

Cyclosporin analogues for preventing or treating hepatitis C infection

ENANTA PHARM INC2 citations63
US8349312B2Jan 8, 2013

Proline substituted cyclosporin analogues

ENANTA PHARM INC4 citations63
US12281140B2Apr 22, 2025

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC0 citations62
US10947264B2Mar 16, 2021

Process for preparation of sulfonylurea bile acid derivatives

ENANTA PHARM INC0 citations62
US8906853B2Dec 9, 2014

[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection

ENANTA PHARM INC2 citations58
US11345699B2May 31, 2022

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations52
US10138228B2Nov 27, 2018

Isoxazole derivatives as FXR agonists and methods of use therof

ENANTA PHARM INC1 citations52
US9616099B2Apr 11, 2017

Cyclosporin analogues for preventing or treating hepatitis C infection

ENANTA PHARM INC0 citations52
US9603895B2Mar 28, 2017

Cyclosporin analogues for preventing or treating hepatitis C infection

ENANTA PHARM INC0 citations52
US8921573B2Dec 30, 2014

Processes for the preparation of novel benzimidazole derivatives

ENANTA PHARM INC2 citations52
US8354383B2Jan 15, 2013

6,11-bridged biaryl macrolides

ENANTA PHARM INC1 citations52

OR YAT SUN

4 patents

SHENZHEN FUTAIHONG PREC IND CO

1 patent

LONG JIANG

1 patent

LONG TAO

1 patent

GAO XURI

1 patent

MITSUBISHI ELECTRIC RES LAB

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.